We serve Chemical Name:Avastin CAS:216974-75-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Avastin
CAS.NO:216974-75-3
Synonyms:Lithium 4-{[2-(diethylamino)ethyl]carbamoyl}-2-iodobenzoate;Benzoic acid, 4-[[[2-(diethylamino)ethyl]amino]carbonyl]-2-iodo-, lithium salt (1:1)
Molecular Formula:C14H18ILiN2O3
Molecular Weight:396.150
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:396.052216
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Lithium 4-{[2-(diethylamino)ethyl]carbamoyl}-2-iodobenzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzoic acid, 4-[[[2-(diethylamino)ethyl]amino]carbonyl]-2-iodo-, lithium salt (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Lithium 4-{[2-(diethylamino)ethyl]carbamoyl}-2-iodobenzoate Use and application,Benzoic acid, 4-[[[2-(diethylamino)ethyl]amino]carbonyl]-2-iodo-, lithium salt (1:1) technical grade,usp/ep/jp grade.
Related News: A strategic CDMO partner who can uphold a strong product manufacturing approach can positively influence timeline, quality, and costs of bringing the drug to market. 5(6H)-Phenanthridinecarboximidamide, N-(3,4-dichlorophenyl)- manufacturers CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells. 6-chloro-N,N-dimethyl-2-(piperazin-1-yl)-4-thiomorpholinopteridin-7-amine suppliers A strategic CDMO partner who can uphold a strong product manufacturing approach can positively influence timeline, quality, and costs of bringing the drug to market. 2-Carbethoxy-3-((phenylseleno)methyl)-1,2,3,4-tetrahydroisoquinoline vendor & factory The growing use of biocatalysis in pharmaceutical chemistry promises to deliver on this need, while also offering substantial cost savings and faster time to market for urgently needed therapeutics. ,CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells.
